We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$508M
AUM Growth
+$11.3M
Cap. Flow
+$5.18M
Cap. Flow %
1.02%
Top 10 Hldgs %
26.12%
Holding
122
New
10
Increased
33
Reduced
37
Closed
13

Top Buys

Rank Stock Value
1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$6.03M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$5.53M
3
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.15M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$5.12M
5
IRTC icon
iRhythm Holdings
IRTC
+$4.03M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.2M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$6.77M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$6.26M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.85M
5
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$4.16M

Sector Composition

Rank Sector Weight
1 Healthcare 95.94%
2 Industrials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
101
Guardant Health
GH
$21.7B
$257K 0.05%
4,770
– –
IONS icon
102
Ionis Pharmaceuticals
IONS
$8.85B
$197K 0.04%
4,450
– –
ASND icon
103
Ascendis Pharma A/S
ASND
$16B
$195K 0.04%
1,890
– –
FUSN
104
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$172K 0.03%
57,297
+19,099
+50% +$47.7K
MEDP icon
105
Medpace
MEDP
$16B
$167K 0.03%
1,060
– –
CRSP icon
106
CRISPR Therapeutics
CRSP
$4.85B
$163K 0.03%
2,490
– –
A icon
107
Agilent Technologies
A
$39.2B
$140K 0.03%
1,148
-100
-8% -$12.8K
NVCR icon
108
NovoCure
NVCR
$1.78B
$122K 0.02%
1,600
+200
+14% +$15.6K
NVAX icon
109
Novavax
NVAX
$1.23B
$46K 0.01%
2,550
-46,650
-95% -$2.02M
JBIO
110
Jade Biosciences
JBIO
$1.16B
– –
-5,601
Closed -$3.06M
ITOS
111
DELISTED
iTeos Therapeutics
ITOS
– –
-147,900
Closed -$3.05M
MASS icon
112
908 Devices
MASS
$343M
– –
-131,757
Closed -$2.71M
MREO
113
Mereo BioPharma
MREO
$53.6M
– –
-385,000
Closed -$431K
MRVI icon
114
Maravai LifeSciences
MRVI
$954M
– –
-89,250
Closed -$2.54M
RARE icon
115
Ultragenyx Pharmaceutical
RARE
$2.46B
– –
-4,300
Closed -$257K
TNDM icon
116
Tandem Diabetes Care
TNDM
$1.39B
– –
-105,763
Closed -$6.26M
TRML
117
DELISTED
Tourmaline Bio
TRML
– –
-22,862
Closed -$1.03M
VIR icon
118
Vir Biotechnology
VIR
$1.48B
– –
-4,200
Closed -$107K
EXAI
119
DELISTED
Exscientia Plc American Depositary Shares
EXAI
– –
-201,388
Closed -$2.19M
CNVY
120
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
– –
-400,000
Closed -$4.16M
TPTX
121
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-90,000
Closed -$6.77M
BHVN
122
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-63,150
Closed -$9.2M
1 2 3 4
5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sectoral Asset Management held 122 positions worth $508M, up 2.3% from $496M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sectoral Asset Management's Q3 2022 filing shows 10 new, 33 increased, 37 reduced and 13 closed positions. Its largest new stake was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q3 2022 buy was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M.
  • Sectoral Asset Management added most to iRhythm Holdings in Q3 2022, an estimated $4.03M increase.
  • Sectoral Asset Management's biggest Q3 2022 reduction was Silk Road Medical, Inc. Common Stock, cutting an estimated $4.85M.
  • Sectoral Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $9.2M.
  • Sectoral Asset Management's ten largest holdings make up 26% of its $508M portfolio in Q3 2022.
  • Sectoral Asset Management opened 10 new positions and closed 13 in Q3 2022.
  • Sectoral Asset Management's portfolio value rose 2.3% quarter-over-quarter to $508M.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.